Insmed: Brinsupri Launch Momentum Supports Overweight Rating and Unchanged $218 Price Target
at www.tipranks.com (Sun, 27-Sep 6:55 PM)
Wall Street Analysts Are Bullish on Top NA Picks
at www.tipranks.com (Thu, 24-Sep 4:40 AM)
Mizuho Securities Sticks to Its Buy Rating for Insmed (INSM)
at www.tipranks.com (Wed, 23-Sep 4:05 AM)
Insmed Wins FDA Priority Review for ARIKAYCE sNDA, Setting a January 28, 2027 PDUFA Date
Market Chameleon (Mon, 21-Sep 8:39 AM)
Insmed Lifts Revenue Targets, Reports Breakout Second Quarter on Brensocatib and Pipeline Progress
Market Chameleon (Thu, 6-Aug 11:14 AM)
Insmed Lifts Revenue Outlook as BRINSUPRI Surges 49% in Q2 and Pipeline Expands
Market Chameleon (Thu, 6-Aug 7:45 AM)
Market Chameleon (Thu, 16-Jul 8:33 AM)
